DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS by Marina V. Shestakova

Subjects: Get full text

Canagliflozin Pharmacokinetics at Steady State in Patients on Maintenance Hemodialysis by Thomas A. Mavrakanas, Amélie Marsot, Efrosyne Tsirella, Norka Rios, Ari Gritsas, Rita S. Suri

Subjects: “…canagliflozin…”
Get full text

Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2) by Ashot A. Avagimyan, Mohammad Sheibani, Artem I. Trofimenko, Evgenii E. Lysov, Farida M. Khamidova, Anahit Z. Aznauryan, Lilit M. Sukiasyan, Karmen T. Sahakyan, Tamara R. Gevorgyan, Marina R. Tatoyan, Gayane L. Mkrtchyan, Goharik L. Meltonyan, Anna R. Petrosyan, Ludmila A. Martemyanova, Ruzanna R. Petrosyan, Olga I. Urazova, Nana V. Pogosova, Nizal Sarrafzadegan

Subjects: Get full text

Canagliflozin protects cardiovascular function in type 2 diabetic coronary artery disease by regulating natriuretic peptide B by Jiarui Zhang, Lichenlu Huang, Yongqin Zheng, Ji Yang, Xiaopei Wu, Jundong He

Subjects: “…Canagliflozin…”
Get full text

An Attention‐Aware Multi‐Task Learning Framework Identifies Candidate Targets for Drug Repurposing in Sarcopenia by Md Selim Reza, Chuan Qiu, Xu Lin, Kuan‐Jui Su, Anqi Liu, Xiao Zhang, Yun Gong, Zhe Luo, Qing Tian, Martin Nwadiugwu, Shaung Liang, Hui Shen, Hong‐Wen Deng

Subjects: Get full text

Formulation and Evaluation of Canagliflozin Self-nanomicellizing Solid Dispersion Based on Rebaudioside A for Dissolution and Solubility Improvement by Nizar Awish Jassem, Shaimaa Nazar Abd Alhammid

Subjects: “…amphiphilic, canagliflozin, nano micelles, phase solubility, Rebaudioside A…”
Get full text

Canagliflozin alleviates acetaminophen-induced renal and hepatic injury in mice by modulating the p-GSK3β/Fyn-kinase/Nrf-2 and p-AMPK-α/STAT-3/SOCS-3 pathways by Abeer Bishr, Bassant M. El-Mokadem, Asmaa A. Gomaa

Subjects: Get full text

A validated multivariable machine learning model to predict cardio-kidney risk in diabetic kidney disease by James L. Jr. Januzzi, Naveed Sattar, Muthiah Vaduganathan, Craig A. Magaret, Rhonda F. Rhyne, Yuxi Liu, Serge Masson, Javed Butler, Michael K. Hansen

Subjects: Get full text

Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now by Alessandro Cuttone, Anastasia Xourafa, Carmela Morace, Vittorio Cannavò, Francesca Maria Bueti, Giuseppe Mandraffino, Giovanni Squadrito, Giorgio Basile, Agostino Gaudio, Antonino Catalano, Giuseppina Tiziana Russo, Federica Bellone

Subjects: Get full text

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus by A. V. Simanenkova, S. M. Minasian, T. L. Karonova, T. D. Vlasov, N. V. Timkina, А. K. Khalzova, O. S. Fuks, A. A. Shimshilashvili, V. A. Timofeeva, Yu. Yu. Borshchev, M. M. Galagudza

Subjects: Get full text

Canagliflozin‐induced renal glutathione distribution mapping in non‐diabetic male rat kidneys by Guy Watanabe, Shoichiro Horita, Reika Flora Moriya, Yusuke Masuishi, Shingen Misaka, Shu Taira, Kenju Shimomura, Michio Shimabukuro, Junichiro James Kazama

Subjects: “…canagliflozin…”
Get full text

Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer’s Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMG... by Hemat A. Elariny, Ahmed M. Kabel, Heba Mohammed Refat M. Selim, Azza I. Helal, Doaa Abdelrahman, Hany M. Borg, Mennatallah A. Elkady, Lamees M. Dawood, Mohamed F. El-Badawy, Haifa Faisal A. Almalawi, El-Shaimaa A. Arafa, Shuruq E. Alsufyani, Hany H. Arab

Subjects: “…canagliflozin…”
Get full text

Effect of canagliflozin combined with alfacalcidol in the treatment of elderly type 2 diabetes mellitus with osteoporosis by HUANG Yi*，JIANGXiong，PENG Jun，GUI Xiao，LIU Shuang，LI Peng，LI Yanling，JIANG Meiling

Subjects: “…canagliflozin…”
Get full text

Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation by N. A. Avxentyev, Yu. V. Makarova

Subjects: Get full text

The role of canagliflozin in the prevention of stroke and chronic kidney disease in patients with type 2 diabetes mellitus: an expert council resolution by M. V. Shestakova, G. R. Galstyan, E. N. Grineva, A. V. Zilov, T. Yu. Demidova, A. M. Mkrtumyan, N. A. Petunina, L. A. Ruyatkina, O. Y. Sukhareva, L. A. Suplotova, M. S. Shamkhalova

Subjects: “…canagliflozin…”
Get full text

Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near by Gilda M. Portalatin, Irene Hong-McAtee, Irene Hong-McAtee, Anna M. Burgner, Edward R. Gould, Tracy E. Hunley, Tracy E. Hunley

Subjects: Get full text

An Observational Study on the Effect of Canagliflozin on Left Ventricular Diastolic Function in Patients with Type 2 Diabetes Mellitus in a Tertiary Care Hospital of West Bengal by Kalyan Kumar Das, Spandan Bhadury, Debasis Chakrabarti

Subjects: “…canagliflozin…”
Get full text

Effects of canagliflozin on cardiovascular disease risk factors in patients with type 2 diabetes: a systematic review and meta-analysis by Hossein Aftabi, Reyhaneh Aftabi

Subjects: “…Canagliflozin…”
Get full text

Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board by M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, T. P. Bardymova, F. V. Valeeva, G. R. Galstyan, T. Yu. Demidova, I. A. Karpova, T. P. Kiseleva, A. Yu. Mayorov, A. M. Mkrtumyan, S. V. Nedogoda, N. А. Petunina, L. A. Ruyatkina, L. A. Suplotova, O. Yu. Sukhareva, V. V. Fadeev, M. S. Shamkhalova

Subjects: “…canagliflozin…”
Get full text

Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells by Ye Yang, Ye Yang, Jieyun Zhou, Qiaoying Lv, Qicheng Ni, Qicheng Ni, Baichun Hu, Yulong Wang, Shuning Qu, Guoting Li, Wenjie Yang, Ruihua Zhong, Xiaojun Chen, Yan Zhu

Subjects: Get full text